Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Stage III to IVa nasopharyngeal cancer (a type of cancer at the back of the nose/throat), confirmed by a pathology test at a major hospital
- People who have not previously received any radiotherapy, chemotherapy, surgery, immunotherapy, or targeted therapy for their cancer
- People who score 80 or above on a standard health and activity scale used by doctors to measure how well a person can carry out daily activities (confirm with trial site)
- People whose mouth lining (inside of the mouth) is healthy and normal before treatment begins
- People aged between 18 and 75 years
- People who are willing to take part voluntarily and able to provide written consent in person
- People whose recent blood test results show healthy levels of white blood cells, red blood cells, neutrophils (infection-fighting cells), and platelets (confirm exact values with trial site)
- People whose recent liver and kidney function test results fall within acceptable ranges (confirm exact values with trial site)
Who may not be able to join:
- People who have had, or currently have, any other type of cancer, or whose cancer has spread to distant parts of the body
- People who have already had surgery, chemotherapy, radiotherapy, or targeted immunotherapy
- People with a history of asthma, rashes, hives, or other allergic conditions
- People with a history of autoimmune diseases, connective tissue diseases, or diabetes that may affect how wounds or mouth sores heal
- People with existing heart disease, kidney disease, or active infectious diseases that a doctor judges could put them at serious risk or prevent them from completing the study
- People who are currently breastfeeding, pregnant, or planning to become pregnant during the study period
- People with known allergies to penicillin or to any of the treatment medications used in this trial
- People with mental health or nervous system conditions, or those who may have difficulty following the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haiqing Luo, Specialty of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University
Phone: +8613729196345
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Radiation-Induced Oral Mucositis (RIOM); Severity of Radiation-Induced Oral Mucositis (RIOM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.